Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.

Hagerman R, Jacquemont S, Berry-Kravis E, Des Portes V, Stanfield A, Koumaras B, Rosenkranz G, Murgia A, Wolf C, Apostol G, von Raison F.

Sci Rep. 2018 Nov 19;8(1):16970. doi: 10.1038/s41598-018-34978-4.

2.

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S.

Nat Rev Drug Discov. 2018 Apr;17(4):280-299. doi: 10.1038/nrd.2017.221. Epub 2017 Dec 8. Review.

PMID:
29217836
3.

Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies.

Trenkwalder C, Stocchi F, Poewe W, Dronamraju N, Kenney C, Shah A, von Raison F, Graf A.

Mov Disord. 2016 Jul;31(7):1054-8. doi: 10.1002/mds.26585. Epub 2016 May 23.

PMID:
27214258
4.

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.

Bailey DB Jr, Berry-Kravis E, Wheeler A, Raspa M, Merrien F, Ricart J, Koumaras B, Rosenkranz G, Tomlinson M, von Raison F, Apostol G.

J Neurodev Disord. 2016;8:1. doi: 10.1186/s11689-015-9134-5. Epub 2015 Dec 15.

5.

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.

Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, Brinkman M, Rerat K, Koumaras B, Zhu L, Barth GM, Jaecklin T, Apostol G, von Raison F.

Sci Transl Med. 2016 Jan 13;8(321):321ra5. doi: 10.1126/scitranslmed.aab4109.

PMID:
26764156
6.

Development of mavoglurant and its potential for the treatment of fragile X syndrome.

Gomez-Mancilla B, Berry-Kravis E, Hagerman R, von Raison F, Apostol G, Ufer M, Gasparini F, Jacquemont S.

Expert Opin Investig Drugs. 2014 Jan;23(1):125-34. doi: 10.1517/13543784.2014.857400. Epub 2013 Nov 20. Review.

PMID:
24251408
7.

The challenges of clinical trials in fragile X syndrome.

Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B.

Psychopharmacology (Berl). 2014 Mar;231(6):1237-50. doi: 10.1007/s00213-013-3289-0. Epub 2013 Oct 31. Review.

8.

Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations.

Diener L, Hugonot-Diener L, Alvino S, Baeyens JP, Bone MF, Chirita D, Husson JM, Maman M, Piette F, Tinker A, von Raison F; European Forum for Good Clinical Practice Geriatric Medicine Working Party.

J Nutr Health Aging. 2013 Jul;17(7):625-7. doi: 10.1007/s12603-013-0340-0.

PMID:
23933874
9.

Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS).

Ryvlin P, Kälviäinen R, Von Raison F, Giordano S, Emir B, Chatamra K.

Eur J Neurol. 2010 May;17(5):726-32. doi: 10.1111/j.1468-1331.2009.02916.x. Epub 2010 Jan 25.

PMID:
20113339
10.

Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.

Lefaucheur JP, Gurruchaga JM, Pollin B, von Raison F, Mohsen N, Shin M, Ménard-Lefaucheur I, Oshino S, Kishima H, Fénelon G, Rémy P, Cesaro P, Gabriel I, Brugières P, Keravel Y, Nguyen JP.

Eur Neurol. 2008;60(4):186-99. doi: 10.1159/000148246. Epub 2008 Jul 31.

PMID:
18667827
11.

Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up.

Hariz MI, Krack P, Alesch F, Augustinsson LE, Bosch A, Ekberg R, Johansson F, Johnels B, Meyerson BA, N'Guyen JP, Pinter M, Pollak P, von Raison F, Rehncrona S, Speelman JD, Sydow O, Benabid AL.

J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):694-9. Epub 2007 Sep 26.

PMID:
17898034
12.

Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.

Lefaucheur JP, Drouot X, Von Raison F, Ménard-Lefaucheur I, Cesaro P, Nguyen JP.

Clin Neurophysiol. 2004 Nov;115(11):2530-41.

PMID:
15465443
13.

A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks.

Lefaucheur JP, Gregson NA, Gray I, von Raison F, Bertocchi M, Créange A.

J Neurol Neurosurg Psychiatry. 2003 Nov;74(11):1555-61.

14.

[Early diagnosis of bacterial brain abscesses: interest of diffusion-weighted MRI].

Detante O, von Raison F, Brugières P, Palfi S, Le Guerinel C, Djindjian M, Degos JD.

Rev Neurol (Paris). 2003 Apr;159(4):421-4. French.

PMID:
12773871
15.

Acute demyelinating disease after interferon beta-1a treatment for multiple sclerosis.

Von Raison F, Abboud H, Saint Val C, Brugières P, Césaro P.

Neurology. 2000 Nov 14;55(9):1416-7. No abstract available.

PMID:
11087800

Supplemental Content

Loading ...
Support Center